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http://dx.doi.org/10.1016/j.pedneo.2An 8.7-year-old boy was affected by exertional dyspnea with cyanosis of the lip at 6 years old.
Oxygen saturation (SpO2) was 66%. A bidirectional Glenn shunt (BGS) was constructed to suc-
cessfully elevate SpO2 to 88%. Unfortunately, he again experienced exertional dyspnea with
flagrant cyanosis of the lip at 8.5 years old. SpO2 decreased to 65%. Echocardiography revealed
a dysplastic pulmonary valve with severe stenosis. Considering the potential growth of the
right ventricle and the branch pulmonary arteries, transjugular balloon pulmonary valvulo-
plasty (BPV) through a BGS was performed as a palliative treatment for cyanosis in this boy
because of inaccessible femoral veins. After gradational BPV, the opening of the pulmonary
valve was dilated from 2.59 mm to 6.65 mm, the pressure gradient decreased from 60 mmHg
to 25 mmHg, and the SpO2 increased to 85%. He became physically active and was free of ex-
ertional dyspnea at the 12-month follow-up. BGS is irrefutably an alternative vascular access
through which transjugular BPV could be performed to ameliorate cyanosis due to dysplastic
pulmonary valve stenosis in patients with inaccessible femoral vessels.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.partment of Pediatrics, Changhua Christian Hospital, Number 135, Nan-Shao Street, Changhua 50050,
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146 M.-L. Lee1. Introduction
Since the pioneer report describing a technique of using the
radial forces of balloon inflation of a balloon catheter
positioned across the pulmonary valve, balloon pulmonary
valvuloplasty (BPV) has become the treatment of choice for
isolated valvular pulmonary stenosis because of its excel-
lent long-term results and minimal complications.1 This
paper reports the case of an 8.7-year-old boy presenting
with cyanosis due to severe dysplastic pulmonary valve
stenosis, which was treated successfully by transjugular
BPV through a bidirectional Glenn shunt (BGS). The clinical
dilemma encountered at performing interventional cardiac
catheterization through alternative vascular access in some
patients with congenital heart diseases will be briefly
discussed.
2. Case Report
An 8.7-year-old boy, who had been treated by radio-
frequency guidewire pulmonary valvotomy (RFPV) for pul-
monary atresia with intact ventricular septum (PAIVS; Z-
value was e 4.5 and was e 1.5 for the pulmonary valve and
the tricuspid valve, respectively) since birth, presented with
exertional dyspnea with cyanosis of the lip at 6 years old. A
BGS was constructed at that time to treat the cyanosis.
Oxygen saturation (SpO2) was elevated significantly from
66% to 88% after BGS. Unfortunately, exertional dyspnea
with cyanosis of the lip became especially bothersome at
8.5 years old. At the outpatient clinic, SpO2 decreased to
65%. Two-dimensional echocardiography showed a small
opening (2.59 mm) in the dysplastic pulmonary valve. The
pulmonary valve and tricuspid valve measured 6.5 mm and
11.2 mm in diameter, respectively. Intra-atrial right-to-left
shunting through incompetent patent foramen ovale (4 mm)
was present. However, transthoracic echocardiography
could not accurately estimate the transvalvular pressure
gradient or assess the severity of valvular pulmonary ste-
nosis. The patient had mild pulmonary regurgitation. He was
admitted for cardiac catheterization to assess the severity
of pulmonary valve stenosis. At admission, he was 8.7 years
old, 17.6 kg in weight, and 113 cm in height. His heart rate
was 100/min, respiratory rate 20/min, and blood pressure
100/80 mmHg. A plain chest film showed cardiomegaly
(cardiothoracic ratio of 70%) and decreased pulmonary
vascularity. The patient’s hemoglobin level was 17.5 g/dL
and hematocrit 52%. A blood coagulation study, liver func-
tion test, and renal function test were within normal limits.
We did not prescribe a prophylactic antibiotic. At cardiac
catheterization, both femoral veins were found to be inac-
cessible by a routine Seldinger maneuver. Instead, we used
a transjugular approach. Prior to transjugular BPV, the peak
systolic pressure of the right ventricle (RV) was 70 mmHg
and that of the main pulmonary artery (MPA) was 10 mmHg.
There was no significant pressure gradient between the
superior vena cava (SVC), BGS, MPA, and branch pulmonary
arteries. The ratio of systolic RV pressure to systolic aortic
pressure (sRV/sAo) was 70%. Countercurrent angiography of
the MPA showed a scanty jetting of dye from the MPA
through a tiny opening in the dysplastic pulmonary valve to
a hypoplastic bipartite RV (Figure 1A). A 0.035-inch AmplatzSuper Stiff (Medi-tech, Boston, MA, USA) was housed in a 4-
Fr Multipurpose Catheter (Cordis, Johnson-Johnson, LJ
Roden, The Netherlands) and advanced as a system from the
right internal jugular vein, SVC, BGS, right pulmonary ar-
tery, MPA, pulmonary valve, RV, and right atrium, and was
finally left anchored deep into the inferior vena cava. A
balloon catheter was railed along the guidewire to cross
over and override the dysplastic pulmonary valve. Two
sets of Wanda Balloon Catheters (8.0 mm  20 mm;
12.0 mm  20 mm; Wanda, Galway, Ireland) were used to
dilate the pulmonary valve gradationally. BPV was consid-
ered complete only when the narrow waist of the inflated
balloon disappeared (Figures 1B and 1C). After transjugular
BPV, the systolic pressure of the RV decreased to 40 mmHg
and that of the MPA was increased to 15 mmHg. The trans-
valvular pressure gradient decreased from 60 mmHg to
25 mmHg, and sRV/sAo ratio decreased from 70% to 40%. RV
angiogram showed an increased diameter of the opening of
the dysplastic pulmonary valve (Figure 1D). SpO2 increased
remarkably to 85%. The patient was free of exertional dys-
pnea and cyanosis of the lip at the 12-month follow-up. In
summary, transjugular BPV through a BGS can be performed
to relieve the patient from the bothersome cyanosis caused
by dysplastic pulmonary valve stenosis.Discussion
RFPV has been advocated as a treatment of choice for pa-
tients with PAIVS, provided that patent infundibulum is
present and RV-dependent coronary circulation (RVDCC) is
absent.2 RFPV was considered a definite treatment for
PAIVS, if the Z-value of the tricuspid valve was 0.1 or
higher and that of the pulmonary valve was 4.1 or higher;3
however, the cutoff Z-values of the pulmonary valve and
the tricuspid valve as prerequisites for RFPV remain to be
determined. RV steal phenomenon is potentially associated
with ventriculocoronary circulation in patients with PAIVS;
however, the presence of ventriculocoronary circulation
alone, but without RVDCC, did not preclude RFPV in pa-
tients with PAIVS.
Although the femoral vein is the most preferred route
for BPV, alternative routes through the jugular vein,4 axil-
lary vein,5 and hepatic vein6 have been applied successfully
in patients with inaccessible femoral veins. Indications of
transjugular cardiac catheterization included thrombosis of
the inferior vena cava, myocardial biopsy after cardiac
transplant, evaluation of patency of the total cavopulmo-
nary connection (TCPC), SVC obstruction after the Mustard
operation, failed transfemoral venous approach, and
absence of the hepatic segment of the inferior vena cava.4
The hepatic vein is another safe and effective route for
interventional procedures in patients with limited venous
access due to conditions such as bilateral obstructed
femoral veins, and obstructed femoral veins and SVC, etc.6
The circumstances under which alternative vascular
access should be used to perform interventional catheter-
ization merit discussion. First, femoral veins might be
sacrificed by puncture or cutdown for repeated BPV in small
patients with residual pulmonary valve restenosis following
RFPV for PAIVS. Second, superior cavopulmonary connec-
tion, initially constructed in patients with univentricular
Figure 1 (A) Prior to transjugular BPV, the countercurrent angiography of the MPA showed scanty blood flow jetting from the MPA
to the hypoplastic RV. The opening of the dysplastic pulmonary valve was 2.59 mm in diameter. (B and C) BPV was performed and
was considered complete only when the narrow waist of the balloon disappeared. (D) After gradational BPV, repeated RV angi-
ography showed mild tricuspid regurgitation. The opening in the dysplastic pulmonary valve was dilated from 2.59 mm to 6.65 mm
in diameter, with an increment of 157%.
Transjugular balloon pulmonary valvuloplasty 147heart and MPA atresia prior to a definite repair of total
cavopulmonary connection, may render transfemoral
balloon angioplasty not feasible, for the dominant RV is
congenitally unconnected to the atretic MPA and pulmonary
arteries. Third, interruption of the inferior vena cava with
continuation of the azygos vein will make transfemoral BPV
or balloon angioplasty demanding in heterotaxy syndrome
or left atrial isomerism, which frequently manifests
cyanosis due to pulmonary stenosis. Fourth, in patients with
transposition of the great arteries complicated with left
ventricular outflow tract obstruction (pulmonary valve/ar-
tery stenosis) or SVC obstruction after the Mustard opera-
tion, transjugular approach for BPV or balloon angioplasty is
a useful alternative.
Transjugular BPV or balloon angioplasty has rarely been
reported in patients with pulmonary valve/artery stenosis.
Reluctance of cardiologists to perform transjugular BPV or
angioplasty may be due to unfamiliarity with the landmark
of the internal jugular vein, the technique of balloon
floating maneuver,7 potential complication by inserting
larger catheters and sheaths into smaller patients, and
anecdotal reports of transjugular cardiac catheterization.
Ultrasound-aided cannulation of the internal jugular vein
may be a preferred technique to improve success rate,
decrease access time, and substantially reduce complica-
tion rates.8 By the aid of a 0.035-inch superstiff guidewire,the balloon catheter can be manipulated from the internal
jugular vein to float into the MPA 180 degrees inverted.
Stabilization of the balloon catheter can also be achieved
by railing on a 0.035-inch superstiff guidewire at trans-
jugular BPV. Shorter balloons are likely to slip distally, and
longer balloons can act as juggernauts to inadvertently
damage the tricuspid valve. Caution must be taken not to
tract the balloon catheters too far backward to prevent
distal slipping, by which we may shorten the looped balloon
catheter and damage the tricuspid valve ineluctably.
However, a balloon floating maneuver can be used to
overcome the dynamic flow caused by severe tricuspid
regurgitation and dilatation of the right atrium in patients
with severe valvular pulmonary stenosis.
In brief, BGS is an executable alternative route of
vascular access, through which transjugular BPV could be
performed to ameliorate cyanosis due to dysplastic pul-
monary valve stenosis in a patient with inaccessible femoral
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